Dr. Alexey V. Danilov
Claim this profileCity of Hope Medical Center
Area of expertise
Mantle Cell Lymphoma
Alexey V. Danilov has run 4 trials for Mantle Cell Lymphoma. Some of their research focus areas include:
Chronic Lymphocytic Leukemia
Alexey V. Danilov has run 4 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:
Affiliated Hospitals
City Of Hope Medical Center
City Of Hope Comprehensive Cancer Center
Clinical Trials Alexey V. Danilov is currently running
Nemtabrutinib + Rituximab
for Mantle Cell Lymphoma
This phase II trial tests how well nemtabrutinib works with rituximab for the treatment of patients with mantle cell lymphoma. Nemtabrutinib is in a class of medications called kinase inhibitors. It blocks a protein called BTK, which is present on B-cell (a type of white blood cells) cancers such as mantel cell lymphoma at abnormal levels. This may help keep cancer cells from growing and spreading. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Giving nemtabrutinib with rituximab may kill more cancer cells in patients with mantle cell lymphoma.
Recruiting
1 award
Phase 2
10 criteria
Zanubrutinib + Odronextamab
for Richter's Transformation
This phase I trial tests the safety and side effects of zanubrutinib in combination with odronextamab and how well it works in treating patients with Richter's transformation. Zanubrutinib, a tyrosine kinase inhibitor, blocks a protein called Bruton tyrosine kinase (BTK), which may help keep cancer cells from growing. Odronextamab is a bispecific monoclonal antibody that can bind to two different antigens at the same time. Odronextamab binds to CD20 found on B-cells (a type of white blood cell) and on many B-cell cancers and to CD3 on T-cells (also a type of white blood cell) and may interfere with the ability of cancer cells to grow and spread. Giving zanubrutinib in combination with odronextamab may be safe, tolerable and/or effective in treating patients with Richter's transformation.
Recruiting
1 award
Phase 1
15 criteria
More about Alexey V. Danilov
Clinical Trial Related
3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Alexey V. Danilov has experience with
- Rituximab
- Venetoclax
- Odronextamab
- Zanubrutinib
- Acalabrutinib
- Ublituximab
Breakdown of trials Alexey V. Danilov has run
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Richter Syndrome
Diffuse Large B-cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexey V. Danilov specialize in?
Alexey V. Danilov focuses on Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia. In particular, much of their work with Mantle Cell Lymphoma has involved CCND1 positive patients, or patients who are del(17p) positive.
Is Alexey V. Danilov currently recruiting for clinical trials?
Yes, Alexey V. Danilov is currently recruiting for 4 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Alexey V. Danilov has studied deeply?
Yes, Alexey V. Danilov has studied treatments such as Rituximab, Venetoclax, Odronextamab.
What is the best way to schedule an appointment with Alexey V. Danilov?
Apply for one of the trials that Alexey V. Danilov is conducting.
What is the office address of Alexey V. Danilov?
The office of Alexey V. Danilov is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.